/CHME

CHME Stock - China Medicine Corporation

Q: What is the analyst price target for CHME?

Analyst price target information is not currently available for CHME.

Q: What is CHME's market cap?

Market capitalization information is not currently available for CHME.

Healthcare|Medical - Distribution|OTC

$0.02+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.03

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for CHME

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2005

FY2006

FY2007

FY2008

FY2009

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta11.80

52W High$0.04

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2009	FY2008	FY2007	FY2006	FY2005
Revenue	$64.75M	$53.65M	$42.11M	$23.99M	N/A
Gross Profit	$18.98M	$15.57M	$12.40M	$8.97M	N/A
Gross Margin	29.3%	29.0%	29.4%	37.4%	N/A
Operating Income	$12.27M	$10.93M	$8.41M	$6.18M	$-32,500
Net Income	$1.72M	$9.13M	$6.88M	$4.79M	$-32,500
Net Margin	2.7%	17.0%	16.3%	20.0%	N/A
EPS	$0.11	$0.60	$0.56	$0.65	$-0.01

Company Overview

China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.

Visit Website

Frequently Asked Questions about CHME

What is CHME's current stock price?

China Medicine Corporation (CHME) is currently trading at $0.02 per share. The stock has moved +0.00% today.

What is the analyst price target for CHME?

No analyst price targets are currently available for this stock.

What sector is China Medicine Corporation in?

China Medicine Corporation operates in the Healthcare sector, specifically within the Medical - Distribution industry. The company is traded on the OTC exchange.

What is CHME's market cap?

China Medicine Corporation has a market capitalization of $0.00 billion, making it a small-cap company.

Does CHME pay dividends?

No, China Medicine Corporation does not currently pay a dividend to shareholders.